Monopar Therapeutics Inc (NASDAQ:MNPR)’s traded shares stood at 0.29 million during the last session, with the company’s beta value hitting 1.21. At the close of
Monopar Therapeutics Inc (NASDAQ:MNPR) has a beta value of 1.22 and has seen 0.41 million shares traded in the recent trading session. The company, currently
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
